التيار الوطني الحر
التيار الوطني الحر
جاهز للتشغيل
جاهز للتشغيل
A recent scientific study has shown that certain antibodies may lead to premature birth in some women by targeting the protein "IL-1RA," which inhibits a pro-inflammatory molecule called "IL-1 beta" responsible for stimulating uterine contractions. The presence of these antibodies was detected early in pregnancy, and their levels were higher in women who gave birth before 37 weeks compared to those who delivered at the scheduled time. Experiments on mice confirmed that disabling this protein results in increased inflammation and signs of placental damage similar to those observed in human preterm births. Researchers suggested that the drug "Kineret," used to treat inflammation, could potentially be used for prevention in the future, but further studies are needed to confirm its effectiveness and safety during pregnancy. Although these findings are significant, the discovered antibodies were not the cause in all cases of preterm birth, indicating that other factors may also contribute to this condition.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading